≡ Menu

Senators Stand Up for ME/CFS – Support Push For FDA Stakeholder Meeting

Posted by Cort Johnson

Thanks to Senator Robert Casey (PA) and his colleagues Senator Richard Blumenthal (CT) and Senator Kay Hagan (NC)

At the end of June, Senators Casey, Blumenthal and Hagan sent a letter to Secretary of Health Kathleen Sebelius requesting  the FDA hold a stakeholders meeting on chronic  fatigue syndrome. All three Senators serve on the Committee on Health, Education, Labor and Pensions which oversees the FDA. The letter stated

“CFS/ME represents a significant unmet medical need, one that confers on patients a lifetime of illness.  A stakeholder meeting would be of great benefit, as it would offer an opportunity to examine existing treatment protocols known to FDA, address how risk/benefit determinations should be made in relation to CFS/ME treatments and identify a path forward for regulatory science in this area.” 

 

Thanks again to the patient community for your emails and some brave folks who met with numerous Congressional offices in Washington DC – our voices have been heard. As you know, Dr. Janet Woodcock, head of the Center for Drug Evaluation and Research, has committed to the stakeholder meeting for ME/CFS.

We are grateful to these Senators for realizing our plight and choosing to engage our health officials in finding solutions.

Comments on this entry are closed.